A randomized study of coconut oil versus sunflower oil on cardiovascular risk factors in patients with stable coronary heart disease

Indian Heart Journal

Volumn 68, Issue 4, 2016, Pages 498-506

  Vijayakumar, Maniyal ^a   Vasudevan, D M ^a   Sundaram, K R ^a   Krishnan, Sajitha ^a   Vaidyanathan, Kannan ^a   Nandakumar, Sandya ^a   Chandrasekhar, Rajiv ^a   Mathew, Navin ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atherosclerosis; Cholesterol; Coconut oil; Cooking medium; Sunflower oil

Indexed keywords

COCONUT OIL; LIPOPROTEIN A; SUNFLOWER OIL; FAT INTAKE; LIPID; VEGETABLE OIL;

ADULT; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; COLORIMETRY; CONTROLLED STUDY; FEMALE; FLOW-MEDIATED VASODILATION; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SINGLE BLIND PROCEDURE; TURBIDIMETRY; VASODILATATION; WAIST HIP RATIO; BLOOD; CORONARY DISEASE; FAT INTAKE; FOLLOW UP; INCIDENCE; MIDDLE AGED; PILOT STUDY; TIME FACTOR;

CORONARY DISEASE; DIETARY FATS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INDIA; LIPIDS; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT OILS; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84969961942     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2015.10.384     Document Type: Article

References (44)

1. Stamler, J., Wentworth, D., Neaton, J.D., Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screeners of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256 (1986), 2823–2828.
2. Neaton, J.D., Blackburn, H., Jacobs, D., et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 152 (1992), 1490–1500.
3. Lloyd-Jones, D.M., Wilson, P.W., Larson, M.G., et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 94 (2004), 20–24.
4. Musunuru, K., Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 45 (2010), 907–914.
5. Mensink, R.P., Zock, P.L., Kester, A.D., Katan, M.B., Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77 (2003), 1146–1155.
6. The Lipid Research Clinics Coronary Primary Prevention Trial results II, The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251 (1984), 365–374.
7. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339 (1998), 1349–1357.
8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994), 1383–1389.
9. Robins, S.J., Collins, D., Wittes, J.T., et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285 (2001), 1585–1591.
10. Sever, P.S., Poulter, N.R., Dahlöf, B., et al. Reduction in cardiovascular events with atorvastatin in 2532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–lipid-lowering arm (ASCOT-LLA). Diabetes Care 28 (2005), 1151–1157.
11. Keene, D., Price, C., Shun-Shin, M.J., Francis, D.P., Effect on cardiovascular risk of high-density lipoprotein targeted treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomized, controlled trials including 117,411 patients. BMJ, 349, 2014, g4379.
12. Kutty, V.R., Balakrishnan, K.G., Jayasree, A.K., Thomas, J., Prevalence of coronary heart disease in the rural population of Thiruvananthapuram district, Kerala, India. Int J Cardiol 39 (1993), 59–70.
13. Thankappan, K.R., Shah, B., Mathur, P., et al. Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res 131 (2010), 53–63.
14. Bach, A.C., Babayan, V.K., Medium-chain triglycerides: an update. Am J Clin Nutr 36 (1982), 950–962.
15. DeLany, J.P., Windhauser, M.M., Champagne, C.M., Bray, G.A., Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr 72 (2000), 905–911.
16. Kumar, P.D., The role of coconut and coconut oil in coronary heart disease in Kerala, south India. Trop Doctor 27 (1997), 215–217.
17. Liau, K.M., Lee, Y.Y., Chen, C.K., Rasool, A.H., An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol, 2011, 2011, 949686.
18. Feranil, A.B., Duazo, P.L., Kuzawa, C.W., Adair, L.S., Coconut oil is associated with a beneficial lipid profile in pre-menopausal women in the Philippines. Asia Pac J Clin Nutr 20 (2011), 190–195.
19. Sabitha, P., Vaidyanathan, K., Vasudevan, D.M., Kamath, P., Comparison of lipid profile and antioxidant enzymes among south Indian men consuming coconut oil and sunflower oil. Indian J Clin Biochem 24 (2009), 76–81.
20. Sabitha, P., Vasudevan, D.M., Kamath, P., Effect of high fat diet without cholesterol supplementation on oxidative stress and lipid peroxidation in New Zealand white rabbits. J Atheroscler Thromb 17 (2010), 213–218.
21. Palazhy, S., Kamath, P., Rajesh, P.C., Vaidyanathan, K., Nair, S.K., Vasudevan, D.M., Composition of plasma and atheromatous plaque among coronary artery disease subjects consuming coconut oil or sunflower oil as the cooking medium. J Am Coll Nutr 31 (2012), 392–396.
22. Kastorini, C.M., Milionis, H.J., Esposito, K., Giugliano, D., Goudevenos, J.A., Panagiotakos, D.B., The effect of Mediterranean diet on metabolic syndrome and its components a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57 (2011), 1299–1313 [Medline].
23. Nordmann, A.J., Suter-Zimmermann, K., Bucher, H.C., et al. Meta-analysis comparing mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 124 (2011), 841–851 e2. [Medline].
24. Kromhout, D., Giltay, E.J., Geleijnse, J.M., n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363 (2010), 2015–2026 [Medline].
25. Raper, N., Perloff, B., Ingwersen, L., Steinfeldt, L., Anand, J., An overview of USDA's dietary intake data system. J Food Compos Anal 17 (2004), 545–555.
26. Moshfegh, A.J., Rhodes, D.G., Baer, D.J., et al. The U.S. Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr 88 (2008), 324–332.
27. Hebert, J.R., Ockene, I.S., Hurley, T.G., Luippold, R., Well, A.D., Harmatz, M.G., Development and testing of a seven-day dietary recall. Dietary Assessment Working Group of the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Clin Epidemiol 50 (1997), 925–937.
28. Labounty, T.M., Gomez, M.J., Achenbach, S., et al. Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients. Eur Heart J Cardiovasc Imaging 14 (2013), 456–463.
29. Seidell, J.C., Pérusse, L., Després, J.-P., Bouchard, C., Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 74 (2001), 315–321.
30. Sniderman, A.D., Furberg, C.D., Keech, A., et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361 (2003), 777–778.
31. Iqbal, R., Anand, S., Ounpuu, S., et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 118 (2008), 1929–1937 Nov 4.
32. Holme, I., Aastveit, A.H., Hammar, N., Jungner, I., Walldius, G., Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 265 (2009), 275–287.
33. Pilz, S., Scharnagl, H., Tiran, B., et al. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J 28 (2007), 2763–2769.
34. Clevidence, B.A., Judd, J.T., Schaefer, E.J., et al. Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids. Arterioscler Thromb Vasc Biol 17 (1997), 1657–1661.
35. Carlson, L.A., Hamsten, A., Asplund, A., Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med, 226, 1989, 271.
36. Koenig, W., Karakas, M., Zierer, A., et al. Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. Clin Chem 57 (2011), 1196–1200.
37. Young, I.S., Woodside, J.V., Antioxidants in health and disease. J Clin Pathol 54 (2001), 176–186.
38. Johann Auer, M.D., Robert Berent, M.D., Elisabeth Lassnig, M.D., Bernd Eber, M.D., C-reactive protein and coronary artery disease. Jpn Heart J 43 (2002), 607–619.
39. Yayan, J., Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vasc Health Risk Manag 9 (2013), 435–456.
40. Rifai, N., Ridker, P.M., High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47 (2001), 403–411.
41. Fox, C.S., Sullivan, L., D'agostino, R.B., Wilson, P.W.F., The significant effect of diabetes duration on coronary heart disease mortality. Diabetes Care, 27, 2004.
42. Jaarin, K., Norliana, M., Kamisah, Y., Nursyafiza, M., Qodriyah, H.M.S., Potential role of virgin coconut oil in reducing cardiovascular risk factors. Exp Clin Cardiol, 20, 2014, 3399.
43. Veerasamy, M., Bagnall, A., Neely, D., Allen, J., Sinclair, H., Kunadian, V., Endothelial dysfunction and coronary artery disease: a state of the art review. Cardiol Rev 23 (2015), 119–129.
44. Poredos, P., Jezovnik, M.K., Testing endothelial function and its clinical relevance. Atheroscler Thromb 20 (2013), 1–8 [Epub 2012 Sep 10].